Feeds:
Posts
Comments

Posts Tagged ‘MEDICAL NEWS TODAY’

MEDICAL NEWS TODAY: Many men at risk for the cancer still aren’t aware of all available treatment options, a new survey suggests. READ MORE>

Read Full Post »

MEDICAL NEWS TODAY: Time of surgery, median PSA level, year of surgery and non-nerve sparing surgical technique are significant predictors of bladder neck contracture after radical prostatectomy, British research has found. READ MORE>

Read Full Post »

MEDICAL NEWS TODAY: A novel genetic mechanism that may govern an individual’s risk of developing prostate cancer has been identified by researchers at the University of Southern California. READ MORE>

Read Full Post »

AUGUST 6: MEDICAL NEWS TODAY:  The US Food and Drug Administration (FDA) has approved the trade name FIRMAGON (degarelix for injection) for its prostate cancer treatment previously marketed under the generic name degarelix. READ MORE>

Read Full Post »

AUGUST 5: MEDICAL NEWS TODAY: Age doesn’t make a difference in the long-term therapeutic outcomes of treating prostate cancer, a new study by scientists has found. READ MORE>

Read Full Post »

JULY 31: MEDICAL NEWS TODAY: Trusted health care sources and continuity of care may help reduce the risk of prostate cancer deaths in African-American men, according to a study published in the current issue of the journal Cancer. READ MORE>

Read Full Post »

JULY 12: MEDICAL NEWS TODAY: A new 12-month hormone therapy treatment administered by an implant has been launched in the UK for men with advanced prostate cancer. The Vantas® (histrelin) implant is a small and flexible device, made from the same materials as soft contact lenses. Vantas® is the first 12-month implant to treat prostate cancer to be available in the UK. READ MORE>

Read Full Post »

« Newer Posts